Romania
· Delayed Price · Currency is RON Med Life Statistics
Total Valuation
Med Life has a market cap or net worth of RON 3.26 billion. The enterprise value is 4.79 billion.
| Market Cap | 3.26B |
| Enterprise Value | 4.79B |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Med Life has 531.06 million shares outstanding.
| Shares Outstanding | 531.06M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 39.25% |
| Owned by Institutions (%) | 27.75% |
| Float | 322.60M |
Valuation Ratios
The trailing PE ratio is 180.42 and the forward PE ratio is 61.30.
| PE Ratio | 180.42 |
| Forward PE | 61.30 |
| PS Ratio | 1.32 |
| PB Ratio | 7.49 |
| P/FCF Ratio | 66.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.00, with an EV/FCF ratio of 97.58.
| EV / Earnings | 265.48 |
| EV / Sales | 1.95 |
| EV / EBITDA | 14.00 |
| EV / EBIT | 38.42 |
| EV / FCF | 97.58 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 3.12.
| Current Ratio | 0.73 |
| Quick Ratio | 0.52 |
| Debt / Equity | 3.12 |
| Debt / EBITDA | 4.65 |
| Debt / FCF | 32.40 |
| Interest Coverage | 1.35 |
Financial Efficiency
Return on equity (ROE) is 1.64% and return on invested capital (ROIC) is 3.94%.
| Return on Equity (ROE) | 1.64% |
| Return on Assets (ROA) | 3.04% |
| Return on Capital (ROIC) | 3.94% |
| Revenue Per Employee | 351,701 |
| Profits Per Employee | 2,579 |
| Employee Count | 6,997 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 11.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.07% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +34.07% |
| 50-Day Moving Average | 5.82 |
| 200-Day Moving Average | 4.79 |
| Relative Strength Index (RSI) | 59.43 |
| Average Volume (20 Days) | 155,911 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Med Life had revenue of RON 2.46 billion and earned 18.04 million in profits. Earnings per share was 0.03.
| Revenue | 2.46B |
| Gross Profit | 1.20B |
| Operating Income | 124.69M |
| Pretax Income | 20.99M |
| Net Income | 18.04M |
| EBITDA | 261.61M |
| EBIT | 124.69M |
| Earnings Per Share (EPS) | 0.03 |
Balance Sheet
The company has 130.71 million in cash and 1.59 billion in debt, giving a net cash position of -1.46 billion or -2.75 per share.
| Cash & Cash Equivalents | 130.71M |
| Total Debt | 1.59B |
| Net Cash | -1.46B |
| Net Cash Per Share | -2.75 |
| Equity (Book Value) | 510.02M |
| Book Value Per Share | 0.82 |
| Working Capital | -216.48M |
Cash Flow
In the last 12 months, operating cash flow was 274.14 million and capital expenditures -225.05 million, giving a free cash flow of 49.09 million.
| Operating Cash Flow | 274.14M |
| Capital Expenditures | -225.05M |
| Free Cash Flow | 49.09M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 48.87%, with operating and profit margins of 5.07% and 0.73%.
| Gross Margin | 48.87% |
| Operating Margin | 5.07% |
| Pretax Margin | 0.85% |
| Profit Margin | 0.73% |
| EBITDA Margin | 10.63% |
| EBIT Margin | 5.07% |
| FCF Margin | 1.99% |
Dividends & Yields
Med Life does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 0.55% |
| FCF Yield | 1.51% |
Stock Splits
The last stock split was on September 1, 2023. It was a forward split with a ratio of 4.
| Last Split Date | Sep 1, 2023 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Med Life has an Altman Z-Score of 1.61. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.61 |
| Piotroski F-Score | n/a |